Levomepromazine vs atypical antipsychotics
Leaving the study early ‐ short term ‐ due to lack of efficacy · patients with schizophrenia
It is very uncertain whether levomepromazine changes leaving the study early ‐ short term ‐ due to lack of efficacy compared with atypical antipsychotics (very low certainty).
1 finding from 1 review
- RR 0.83 [0.4, 1.74]2 studies · 106 participantsVery low